Yuvan's E5 therapy receives investment to move into canine trials
Longevity Technology - 31-Aug-2023Pig plasma therapy could reverse aging in humans
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Chief Executive Officer of Yuvan Research
Akshay Sanghavi is the Chief Executive Officer of Yuvan Research. His work mainly focuses on cell aging, DNA methylation, epigenetics, gene regulation, epigenomics, genomics, regulation of gene expression, and transcriptional regulation.
Visit website: https://scholar.google.com/citations?user=0CkC_RgAAAAJ&hl=en
Details last updated 01-Sep-2023
Pig plasma therapy could reverse aging in humans